2,669 Shares in The Clorox Company (NYSE:CLX) Acquired by Bar Harbor Wealth Management
2,669 Shares in The Clorox Company (NYSE:CLX) Acquired by Bar Harbor Wealth Management
Bar Harbor Wealth Management bought a new position in shares of The Clorox Company (NYSE:CLX – Get Rating) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,669 shares of the company's stock, valued at approximately $376,000.
BAR Harbor Wealth Management在第二季度购买了高乐氏公司(NYSE：CLX-GET Rating)股票的新头寸，根据该公司在最近提交给美国证券交易委员会的Form 13F文件中的说法。该机构投资者购买了2669股该公司股票，价值约37.6万美元。
A number of other institutional investors and hedge funds have also recently bought and sold shares of CLX. Federated Hermes Inc. grew its position in Clorox by 71,909.5% in the first quarter. Federated Hermes Inc. now owns 1,044,858 shares of the company's stock valued at $145,267,000 after acquiring an additional 1,043,407 shares in the last quarter. Nuance Investments LLC grew its position in Clorox by 224.7% in the first quarter. Nuance Investments LLC now owns 1,142,363 shares of the company's stock valued at $158,823,000 after acquiring an additional 790,505 shares in the last quarter. Verity Asset Management Inc. acquired a new stake in Clorox in the first quarter valued at approximately $192,000. Candlestick Capital Management LP grew its position in Clorox by 171.4% in the first quarter. Candlestick Capital Management LP now owns 700,000 shares of the company's stock valued at $97,321,000 after acquiring an additional 442,082 shares in the last quarter. Finally, BlackRock Inc. grew its position in shares of Clorox by 3.2% during the first quarter. BlackRock Inc. now owns 11,117,522 shares of the company's stock worth $1,545,669,000 after buying an additional 342,680 shares in the last quarter. Institutional investors and hedge funds own 81.69% of the company's stock.
其他一些机构投资者和对冲基金最近也买卖了CLX的股票。今年第一季度，联合爱马仕公司在高乐氏的持仓增加了71,909.5%。联合爱马仕公司目前拥有1,044,858股该公司股票，价值145,267,000美元，该公司在上个季度又收购了1,043,407股。Nuance Investments LLC在第一季度将其在高乐氏的头寸增加了224.7%。Nuance Investments LLC在上个季度额外收购了790,505股后，现在拥有1,142,363股该公司的股票，价值158,823,000美元。Verity Asset Management Inc.在第一季度收购了Clorox的新股份，价值约为19.2万美元。Candlestick Capital Management LP在第一季度将其在高乐氏的头寸增加了171.4%。Candlestick Capital Management LP在上个季度增持了442,082股后，现在拥有该公司70万股股票，价值97,321,000美元。最后，贝莱德股份有限公司在第一季度增持了高乐氏3.2%的股票。贝莱德股份有限公司现在持有11,117,522股该公司股票，价值1,545,669,000美元，该公司在上个季度又购买了342,680股。机构投资者和对冲基金持有该公司81.69%的股票。
Analyst Ratings Changes
分析师评级发生变化
A number of research firms have recently weighed in on CLX. Evercore ISI began coverage on shares of Clorox in a research report on Monday, October 17th. They set an "underperform" rating for the company. DA Davidson raised their price target on shares of Clorox from $124.00 to $155.00 and gave the stock a "neutral" rating in a research report on Wednesday, November 2nd. Deutsche Bank Aktiengesellschaft raised their price target on shares of Clorox from $138.00 to $148.00 and gave the stock a "hold" rating in a research report on Wednesday, November 2nd. StockNews.com began coverage on Clorox in a research note on Wednesday, October 12th. They set a "hold" rating on the stock. Finally, Barclays raised their price objective on Clorox from $93.00 to $101.00 and gave the stock an "underweight" rating in a research note on Friday, August 19th. Ten investment analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, Clorox has an average rating of "Reduce" and an average price target of $135.08.
最近，许多研究公司都加入了CLX的行列。Evercore ISI在10月17日星期一的一份研究报告中开始报道高乐氏的股票。他们为该公司设定了“表现不佳”的评级。达戴维森将高乐氏股票的目标价从124.00美元上调至155.00美元，并在11月2日周三的一份研究报告中给出了该公司股票的中性评级。11月2日(周三)，德意志银行在一份研究报告中将高乐氏股票的目标价从138.00美元上调至148.00美元，并给予该股“持有”评级。StockNews.com在10月12日星期三的一份研究报告中开始对Clorox进行报道。他们对该股设定了“持有”评级。最后，巴克莱将高乐氏的目标价从93美元上调至101.00美元，并在8月19日星期五的一份研究报告中给出了该股“减持”的评级。10名投资分析师对该股的评级为卖出，4名分析师给出了持有评级，1名分析师给出了该公司股票的买入评级。根据MarketBeat，高乐氏的平均评级为“减持”，平均目标价为135.08美元。
Clorox Trading Down 1.3 %
高乐氏股价下跌1.3%
Clorox Announces Dividend
高乐氏宣布分红
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 10th. Shareholders of record on Wednesday, January 25th will be paid a dividend of $1.18 per share. The ex-dividend date of this dividend is Tuesday, January 24th. This represents a $4.72 annualized dividend and a yield of 3.17%. Clorox's dividend payout ratio (DPR) is presently 144.79%.
该公司最近还宣布了季度股息，将于2月10日(星期五)支付。1月25日(星期三)登记在册的股东将获得每股1.18美元的股息。本次股息除息日为1月24日(星期二)。这意味着年化股息为4.72美元，收益率为3.17%。高乐氏的股息支付率目前为144.79%。
Clorox Profile
高乐氏简介
(Get Rating)
(获取评级)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
高乐氏公司在全球制造和营销消费品和专业产品。它通过四个部分运作：健康和健康，家庭，生活方式和国际。健康与健康部门提供清洁产品，如洗衣添加剂和家居护理产品，主要是Clorox、Clorox2、Scentiva、Pine-Sol、Liquid-Plumr、Tilex和Formula 409品牌；CloroxPro和Clorox Healthcare品牌的专业清洁和消毒产品；隐藏谷品牌的专业食品服务产品；以及美国的RenewLife、Natural Vitality、NeoCell和Rainrow Light品牌的维生素、矿物质和补充剂产品。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Three CBD Stocks to Dominate a Budding Industry
- Institutional Support for Analog Devices Remains High
- 免费获取StockNews.com关于高乐氏的研究报告
- 60/40的投资组合组合还在《时尚》杂志上流行吗？
- 微软股票：是时候备份卡车了吗？
- Salesforce裁员，尽管面临挑战，但收入强劲
- 三只CBD股票将主宰一个萌芽行业
- 机构对ADI的支持仍然很高
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Get Rating).
想看看还有哪些对冲基金持有CLX吗？访问HoldingsChannel.com，获取高乐氏公司(纽约证券交易所代码：CLX-GET评级)的最新13F文件和内幕交易。
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
接受《高乐氏日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Clorox和相关公司的最新新闻和分析师评级的每日简要摘要。